Maravai LifeSciences (MRVI) Misses Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Unity Software stock soars 22% on strong Q3 beat, robust guidance
Tweet
Share
E-mail
Get Alerts MRVI Hot Sheet
Join SI Premium – FREE
Maravai LifeSciences (NASDAQ: MRVI) reported Q1 EPS of $0.03, $0.01 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $79.03 million versus the consensus estimate of $80.86 million.
For earnings history and earnings-related data on Maravai LifeSciences (MRVI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sempra Energy (SRE) Tops Q3 EPS by 20c ; Offers Guidance
- Sabre (SABR) Tops Q3 EPS by 8c
- ScanSource (SCSC) Misses Q1 EPS by 25c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
